Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Victor R DeFilippis
Affiliation
Vaccine and Gene Therapy Institute, Oregon Health and Science University
ORCID
Career Start Year
2000
Papers
60
H Index
30
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37983245
Mayaro virus pathogenesis and immunity in rhesus macaques.
PLoS Negl Trop Dis
2023
31338593
Chikungunya Virus Vaccines: Platforms, Progress, and Challenges.
Curr Top Microbiol Immunol
2022
35471821
Identification and Characterization of Small-Molecule IRF3-Dependent Immune Activators for Pharmaceutical Development.
ACS Chem Biol
2022
35788221
Development of a next-generation chikungunya virus vaccine based on the HydroVax platform.
PLoS Pathog
2022
35849213
Aging alters antiviral signaling pathways resulting in functional impairment in innate immunity in response to pattern recognition receptor agonists.
Geroscience
2022
34152810
Identification of Quinolinones as Antivirals against Venezuelan Equine Encephalitis Virus.
Antimicrob Agents Chemother
2021
33793555
Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses.
PLoS Negl Trop Dis
2021
33835811
Targeting Chikungunya Virus Replication by Benzoannulene Inhibitors.
J Med Chem
2021
34411201
Human cytomegalovirus blocks canonical TGFβ signaling during lytic infection to limit induction of type I interferons.
PLoS Pathog
2021
32117091
The E3 Ubiquitin Ligase SIAH1 Targets MyD88 for Proteasomal Degradation During Dengue Virus Infection.
Front Microbiol
2020
32101570
Herpes simplex virus type 1 inflammasome activation in proinflammatory human macrophages is dependent on NLRP3, ASC, and caspase-1.
PLoS One
2020
32733475
Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner.
Front Immunol
2020
30755509
Human Cytomegalovirus Immediate Early 86-kDa Protein Blocks Transcription and Induces Degradation of the Immature Interleukin-1β Protein during Virion-Mediated Activation of the AIM2 Inflammasome.
mBio
2019
31736977
Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus Disease.
Front Immunol
2019
31257853
Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus.
ACS Infect Dis
2019
30917980
Src Family Kinase Inhibitors Block Translation of Alphavirus Subgenomic mRNAs.
Antimicrob Agents Chemother
2019
31060350
Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist.
ACS Infect Dis
2019
29263267
Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING Pathway.
J Virol
2018
29343712
Zika virus infection in pregnant rhesus macaques causes placental dysfunction and immunopathology.
Nat Commun
2018
28808971
High-Throughput Screening for Identification of Novel Innate Immune Activators.
Methods Mol Biol
2017
28278237
Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues.
PLoS Pathog
2017
28380070
Correction: Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues.
PLoS Pathog
2017
28465426
A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses.
mBio
2017
27874833
A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression.
Elife
2016
27736984
Dysregulated TGF-β Production Underlies the Age-Related Vulnerability to Chikungunya Virus.
PLoS Pathog
2016
25973608
Varicella Viruses Inhibit Interferon-Stimulated JAK-STAT Signaling through Multiple Mechanisms.
PLoS Pathog
2015
26646986
Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses.
PLoS Pathog
2015
26085158
The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation.
J Virol
2015
26018150
Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists.
J Virol
2015
25955717
Human Cytomegalovirus miR-UL112-3p Targets TLR2 and Modulates the TLR2/IRAK1/NFκB Signaling Pathway.
PLoS Pathog
2015
24691437
Cytomegalovirus pp65 limits dissemination but is dispensable for persistence.
J Clin Invest
2014
24013068
The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.
J Mol Biol
2013
24955107
The inflammasome as a target of modulation by DNA viruses.
Future Virol
2013
23936572
Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity.
PLoS Negl Trop Dis
2013
22171275
Viral interferon regulatory factors are critical for delay of the host immune response against rhesus macaque rhadinovirus infection.
J Virol
2012
22749601
Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially.
Vaccine
2012
22396129
Association of human papillomavirus type 31 variants with risk of cervical intraepithelial neoplasia grades 2-3.
Int J Cancer
2012
20962078
Chikungunya virus induces IPS-1-dependent innate immune activation and protein kinase R-independent translational shutoff.
J Virol
2011
22028943
Ebola virion attachment and entry into human macrophages profoundly effects early cellular gene expression.
PLoS Negl Trop Dis
2011
20930069
IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin.
Blood
2011
19846511
Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1.
J Virol
2010
20699190
Viral hijacking of the host ubiquitin system to evade interferon responses.
Curr Opin Microbiol
2010
20573816
Activation of the interferon response by human cytomegalovirus occurs via cytoplasmic double-stranded DNA but not glycoprotein B.
J Virol
2010
19229316
Differential ligand binding to a human cytomegalovirus chemokine receptor determines cell type-specific motility.
PLoS Pathog
2009
18093265
The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants.
Am J Transplant
2008
18637515
Cytomegalovirus immune evasion.
Curr Top Microbiol Immunol
2008
17251289
Rat cytomegalovirus gene expression in cardiac allograft recipients is tissue specific and does not parallel the profiles detected in vitro.
J Virol
2007
17892221
Induction and evasion of the type I interferon response by cytomegaloviruses.
Adv Exp Med Biol
2007
17686866
West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis.
J Virol
2007
17001305
The insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcoma.
Oncogene
2007
1 - 50 of 60
Column Actions
Search
Recommended Authors
David Sachs
Icahn School of Medicine at Mount Sinai
Career Start Year
2013
Number of shared co-authors
0
Shashank Tripathi
Indian Institute of Science
Career Start Year
2011
Number of shared co-authors
2
Ferdinand Roesch
VA-MD Regional College of Veterinary Medicine, Virginia Tech
Career Start Year
2009
Number of shared co-authors
1
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Career Start Year
2008
Number of shared co-authors
1
Suzannah J Rihn
MRC-University of Glasgow Centre for Virus Research, University of Glasgow
Career Start Year
2008
Number of shared co-authors
0
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year
2008
Number of shared co-authors
0
Colm Atkins
Rutgers University
Career Start Year
2007
Number of shared co-authors
0
Koen Bartholomeeusen
Institute of Tropical Medicine
Career Start Year
2007
Number of shared co-authors
0
Sebastian Aguirre
Icahn School of Medicine at Mount Sinaigrid.59734.3c
Career Start Year
2006
Number of shared co-authors
0
Courtney Wilkins
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year
2005
Number of shared co-authors
4
Jan Rehwinkel
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Career Start Year
2004
Number of shared co-authors
0
Cherie T Ng
The Scripps Research Institute
Career Start Year
2004
Number of shared co-authors
0
Sean C Proll
Fred Hutchinson Cancer Research Center
Career Start Year
2001
Number of shared co-authors
5
Benjamin R tenOever
NYU Grossman School of Medicine
Career Start Year
2001
Number of shared co-authors
5
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year
2000
Number of shared co-authors
0
Renate K??nig
Paul-Ehrlich-Institut
Career Start Year
1998
Number of shared co-authors
0
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
1998
Number of shared co-authors
2
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Career Start Year
1996
Number of shared co-authors
2
Abraham L Brass
University of Massachusetts Medical School
Career Start Year
1995
Number of shared co-authors
2
Shelly J Robertson
National Institute of Allergy and Infectious Diseases
Career Start Year
1995
Number of shared co-authors
1
Ana Fernandez-Sesma
Icahn School of Medicine at Mount Sinai
Career Start Year
1993
Number of shared co-authors
5
Ren Sun
University of California los angeles
Career Start Year
1992
Number of shared co-authors
0
Lucy Thorne
University College London
Career Start Year
1992
Number of shared co-authors
1
Keith R Jerome
Fred Hutchinson Cancer Center
Career Start Year
1991
Number of shared co-authors
2
Akiko Iwasaki
Yale University
Career Start Year
1990
Number of shared co-authors
3
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year
1988
Number of shared co-authors
11
Peter Ghazal
UK System Immunity Research Institute, Cardiff University
Career Start Year
1985
Number of shared co-authors
2
Charles M Rice
Rockefeller University
Career Start Year
1981
Number of shared co-authors
10
Michael G Katze
University of Washington
Career Start Year
1978
Number of shared co-authors
7
Robert F Garry
Tulane University School of Medicine
Career Start Year
1974
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
Daniel N Streblow
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers
25
Craig N Kreklywich
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers
14
Jay A Nelson
Oregon Health and Science University
Co-authored papers
11
Alec J Hirsch
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Co-authored papers
8
Michael Denton
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers
7
Thomas E Morrison
University of Colorado Anschutz Medical Campus
Co-authored papers
7
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers
7
Jessica L Smith
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers
7
Jinu Abraham
Oregon Health & Science University
Co-authored papers
5
Janko Nikolich-Zugich
University of Arizona Center on Aging, University of Arizona
Co-authored papers
3
Byung Park
Oregon Health & Science University
Co-authored papers
2
Michael J Gough
Earle A. Chiles Research Institute, Providence Cancer Institute
Co-authored papers
2
Heather L Meyers
Co-authored papers
2
Igor Landais
Vaccine and Gene Therapy Institute, Oregon Health and Sciences University
Co-authored papers
2
Richard D Smith
Pacific Northwest National Laboratory
Co-authored papers
1
Joseph L DeRisi
University of California San Francisco
Co-authored papers
1
Patrizia Caposio
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers
1
Ernesto S Nakayasu
Co-authored papers
1
Ted M Ross
Center for Vaccines and Immunology, University of Georgia
Co-authored papers
1
Xuexiang Zhang
Baruch S. Blumberg Institute
Co-authored papers
1
Meaghan H Hancock
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers
1
Leonidas Stamatatos
Co-authored papers
1
Robert P Searles
Oregon Health & Science University
Co-authored papers
1
Louis J Picker
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers
1
J??rgen Haas
University of Edinburgh
Co-authored papers
1
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers
1
Finn Grey
The Roslin Institute, The University of Edinburgh
Co-authored papers
1
Giselle M Knudsen
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
1
Clayton R Morrison
University of North Carolina School of Medicine
Co-authored papers
1
Laurent Coscoy
University of California Berkeley
Co-authored papers
1
1 - 30